Cingulate Historical Cash Flow
| CING Stock | USD 3.95 0.01 0.25% |
Analysis of Cingulate cash flow over time is an excellent tool to project Cingulate future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 8.6 M or Begin Period Cash Flow of 5.4 M as it is a great indicator of Cingulate ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Cingulate latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cingulate is a good buy for the upcoming year.
Cingulate |
About Cingulate Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Cingulate balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cingulate's non-liquid assets can be easily converted into cash.
Cingulate Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Cingulate to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Cingulate operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Cingulate's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Cingulate current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.At this time, Cingulate's Change To Account Receivables is most likely to increase significantly in the upcoming years. The Cingulate's current Total Cash From Financing Activities is estimated to increase to about 12.2 M, while Change In Cash is forecasted to increase to (4.5 M).
Cingulate cash flow statement Correlations
Click cells to compare fundamentals
Cingulate Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cingulate cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | 17.9K | (814.7K) | (152.7K) | (180.2K) | (162.1K) | (154.0K) | |
| Change In Cash | 779.2K | 15.3M | (11.1M) | (5.3M) | (4.8M) | (4.5M) | |
| Free Cash Flow | (7.2M) | (11.2M) | (16.0M) | (15.3K) | (17.5K) | (18.4K) | |
| Change In Working Capital | (293.5K) | (3.2M) | 598.6K | 7.1M | 8.2M | 8.6M | |
| Begin Period Cash Flow | 418.5K | 1.2M | 16.5M | 5.4M | 6.2M | 5.4M | |
| Other Cashflows From Financing Activities | 7.5M | 6.7M | (152.7K) | 10.0M | 9.0M | 4.9M | |
| Depreciation | 666.0K | 708.3K | 394.0K | 582.9K | 670.4K | 556.6K | |
| Other Non Cash Items | 2.2M | 16.3M | 798.0K | (27.8M) | (25.0M) | (23.7M) | |
| Capital Expenditures | 402.1K | 814.7K | 153.4K | 224.1 | 201.69 | 191.61 | |
| Total Cash From Operating Activities | (6.8M) | (10.4M) | (15.9M) | (15.0M) | (13.5M) | (14.2M) | |
| Change To Account Receivables | (487.3K) | (1.9M) | 1.2M | 5.4M | 6.2M | 6.5M | |
| Net Income | (7.2M) | (20.7M) | (17.7M) | (23.5K) | (27.1K) | (28.4K) | |
| Total Cash From Financing Activities | 8.0M | 26.5M | 4.9M | 10.0M | 11.4M | 12.2M | |
| End Period Cash Flow | 1.2M | 16.5M | 5.4M | 52.42 | 60.28 | 57.27 |
Currently Active Assets on Macroaxis
When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.